EIF2A and Alzheimer disease: Genetic reduction of PERK and GCN2, which are other kinases of eIF2α, ameliorated AD-related phenotypes in synaptic plasticity and behavior in AD mouse models such as APP/PS1 mice and 5XFAD mice [9, 10] (but also see [8]).